Efficacy and safety of rituximab biosimilar in refractory lupus

13:25
 
Share
 

Manage episode 284123086 series 1099819
By BMJ Group. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bangkok, Thailand, about their study on the short term efficacy and safety of rituximab biosimilar in refractory lupus.

Access the paper here: https://lupus.bmj.com/content/7/1/e000442

24 episodes